Compare Bristol-Myers Squibb Co (BMY) vs Krispy Kreme Inc (DNUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Krispy Kreme Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B), while Krispy Kreme Inc trades at $3.12 (market cap $537.85M). The key difference: Bristol-Myers Squibb Co is far larger — about 241.6× Krispy Kreme Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | DNUT | |
|---|---|---|
Market Cap | $129.94B | $537.85M |
Sector | Health | Consumer Staples |
52-Week High | $65.89 | $4.70 |
52-Week Low | $42.60 | $2.92 |
Enterprise Value | $163.92B | $1.78B |
Dividend Yield | 3.96% | 3.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →
